Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

News

Vator Securities advises AlzeCure Pharma on SEK 40 million directed share issue

2 July 2018

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 40 million.

Read More

Sole Bookrunner in the largest ever direct share issue in a diagnostics company in Sweden

12 June 2018

Vator Securities Sole Bookrunner in successful SEK 324 million direct share issue in Immunovia, the largest ever in a diagnostics company in Sweden Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing

Read More

Vator Securities Sole Bookrunner in SEK 324 million direct share issue – the largest in Swedish history in a diagnostics company

12 June 2018

Vator Securities Sole Bookrunner in successful SEK 324 million direct share issue in Immunovia, the largest ever in a diagnostics company in Sweden.

Read More

Vator Securities advises Plastics Unbound on SEK 50 million Private Placement

10 June 2018

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 50 million.

Read More

Vator Securities advises Ascelia Pharma on SEK 60 million Pre-IPO share issue

17 May 2018

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 60 million.

Read More
Homan

Dagens PS Appoints Homan Panahi Entrepreneur of the Week

2 February 2018

“Entrepreneur of the Week” highlights entrepreneurs, innovators and business leaders who shape Swedish commerce.

Read More

Caroline Banér new corporate finance project leader

15 January 2018

Vator Securities announced today that the company strengthens its existing team with Caroline Banér, who will be our new Corporate Finance project leader. Prior to joining Vator Securities, Caroline held an associate role in Corporate Finance and M&A at BDO Sweden.

Read More

Vator Securities appoints Lars Hevreng as Head of Research

8 January 2018

Vator Securities announced today that Lars Hevreng has been appointed as Head of Research and Senior Equity Partner with the firm. Prior to joining Vator Securities, Hevreng served as a top ranked healthcare analyst at major financial institutions such as SEB and most recently Danske Bank.

Read More